Results 121 to 130 of about 229,168 (314)
Extended anticoagulation after venous thromboembolism: should it be done?
Therapeutic Advances in Respiratory Disease, 2019 Most physicians understand venous thromboembolism (VTE) to be an acute and time-limited disease. However, pathophysiological and epidemiological data suggest that in most patients VTE recurrence risk is not resolved after the first 6 months of ...
Caio J. Fernandes +5 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Mitral regurgitation (MR) is the valent type of valvular heart disease, caused by primary leaflet lesions or annular dilatation secondary to left ventricular dysfunction. It can lead to a series of complications such as volume overload, exacerbated pulmonary congestion, and heart failure, significantly impacting patient prognosis ...
Juelian Li +4 more
wiley +1 more source
Journal of International Medical Research, 2019 Objective To analyse the role of anticoagulation therapy in cardiopulmonary resuscitation (CPR) following an in-hospital cardiac arrest. Methods This single-centre retrospective cohort study enrolled patients treated with in-hospital CPR that met the ...
Hai Wang +6 more
doaj +1 more source
Outcomes of Left Atrial Appendage Occlusion in Heart Failure With Reduced Ejection Fraction
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from major trials of left atrial appendage occlusion (LAAO). Aim The objective of this study was to describe this population and evaluate outcomes after LAAO in patients with and without HFrEF.
Aamer Ubaid +4 more
wiley +1 more source
Anticoagulant guidelines [PDF]
British Dental Journal, 2013 Kerr, R., Ogden, G., Sime, G.
openaire +3 more sources
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Unfractionated heparin (UFH) remains the standard anticoagulant during percutaneous coronary intervention (PCI), with guidelines recommending a target activated clotting time (ACT) of ≥250 s. However, despite receiving a standardized bolus dose, many patients fail to achieve this target.
Manh Cuong Vu +9 more
wiley +1 more source
Rate-Control or Rhythm-Contol: Where do we stand? [PDF]
, 2005 Atrial fibrillation is the most common sustained rhythm disturbance and its prevalence is increasing worldwide due to the progressive aging of the population.
A, Dello Russo +6 more
core +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Chronic thromboembolic pulmonary disease (CTEPD) leads to chronic total occlusions (CTOs) of the pulmonary arteries in a minority of patients. Treatment of CTOs with balloon pulmonary angioplasty (BPA) may substantially improve patient hemodynamics but presents unique technical challenges and has previously been associated with a ...
Elliot J. Stein +4 more
wiley +1 more source
Brazilian Journal of Cardiovascular SurgeryIntroduction: In patients with mechanical prosthetic heart valves or atrial fibrillation requiring anticoagulation to prevent thromboembolic events, several factors influence adherence and anticoagulation complications.
Mário Augusto Cray da Costa +5 more
doaj +1 more source
A Case of Venous Tissue Dissection During Transcatheter MitraClip Surgery
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT The MitraClip system has been widely used to treat mitral regurgitation. The complications associated with MitraClip surgery typically include clip detachment and mitral valve injury. However, cases of venous tissue dissection during surgery are relatively rare.
Shumin Ouyang +5 more
wiley +1 more source